Akinlade, Bolanle
Regeneron (United States)
3 papers on CoChatORCID 0000-0003-2334-5717
Most cited papers
- Verified
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
Simpson, E. L., Bieber, T., Guttman-Yassky, E., Beck, L. A., Blauvelt, A., Cork, M. J., Silverberg, J. I., Deleuran, M., Kataoka, Y., Lacour, J.-P., et al. (2016) · New England Journal of Medicine
Dermatology and Skin DiseasesPsoriasis: Treatment and Pathogenesis
Cited by 2,110
- Verified
Conjunctivitis in dupilumab clinical trials
Akinlade, B., Guttman‐Yassky, E., Bruin‐Weller, M., Simpson, E. L., Blauvelt, A., Cork, M. J., Prens, E., Asbell, P., Akpek, E., Corren, J., et al. (2019) · British Journal of Dermatology
Dermatology and Skin DiseasesOcular Surface and Contact Lens
Cited by 442
- Verified
Dupilumab shows long-term safety and efficacy in patients with moderate to severe atopic dermatitis enrolled in a phase 3 open-label extension study
Deleuran, M., Thaçi, D., Beck, L. A., de Bruin-Weller, M., Blauvelt, A., Forman, S., Bissonnette, R., Reich, K., Soong, W., Hussain, I., et al. (2020) · Journal of the American Academy of Dermatology
Dermatology and Skin DiseasesPsoriasis: Treatment and Pathogenesis
Cited by 255
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free